HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
NEO
Neogenomics Inc
Healthcare Diagnostics & Research · Florida, USA · Reports in usd
Market Cap: $1.07B
Market Cap
$1.07B
Enterprise Val
$1.32B
P/E Ratio
-9.93
P/B Ratio
1.28
Trailing PEG (1Y)
0.24
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$836.6M
Gross Margin43.83%
Profit Margin43.83%
Return on Equity-12.64%
Return on Assets-7.54%
Current Ratio4.26
Debt/Equity0.49
LT Debt/Equity0.48
Revenue Per Share1.47

Income Statement

Dec 31, 2025
Revenue$190.2M
Cost of Revenue$106.8M
Gross Profit$83.3M
R&D$9.2M
SG&A$87.0M
Operating Expenses$96.8M
Operating Income-$13.4M
Interest Expense$599.0K
Tax Expense-$2.5M
Net Income-$9.9M
EPS (Basic)$-0.07
EPS (Diluted)$-0.07
EBIT-$11.8M
EBITDA$6.3M
Consolidated Income-$9.9M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$159.6M
Accounts Receivable$159.2M
Inventory$28.6M
Current Assets$376.3M
LT Investments$0.00
Property, Plant & Equipment$163.3M
Intangibles$810.9M
Non-Current Assets$983.5M
Total Assets$1.36B
Accounts Payable$23.1M
Current Debt$4.8M
Current Liabilities$88.3M
LT Debt$404.7M
Non-Current Liabilities$435.0M
Total Liabilities$523.3M
Total Debt$409.5M
Retained Earnings-$433.8M
Shareholder Equity$836.6M
Shares Outstanding129,387,801

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow$1.3M
Investing Cash Flow-$6.3M
Financing Cash Flow$431.0K
CapEx-$7.9M
Free Cash Flow-$6.5M
Depreciation & Amort.$18.1M
Stock-Based Comp$8.0M
Acquisitions / Disposals$2.1M
Investment Activity-$500.0K
Debt Issued/Repaid$0.00
Equity Issued/Repaid$431.0K
Dividends Paid$0.00
Net Change in Cash-$4.5M
Data cached · Meta live · Daily live · Statements live · TTL 24h